Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study

This study has been withdrawn prior to enrollment.
(Unable to obtain funding)
Sponsor:
Collaborators:
University of North Carolina, Chapel Hill
University of Toronto
University of Calgary
Information provided by (Responsible Party):
University of Arkansas
ClinicalTrials.gov Identifier:
NCT01831037
First received: April 2, 2013
Last updated: January 27, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: December 2019
  Estimated Primary Completion Date: June 2019 (Final data collection date for primary outcome measure)